World Orphan Drug Alliance expands to Canada and full LATAM region, completing the first truly global commercialization offering World Orphan Drug Alliance expands to Canada and full LATAM region, completing the first truly global commercialization offering.

Oncopeptides expands on WODA partnership with addition of Africa and Eurasia to provide Pepaxti to Patients Oncopeptides expands on WODA partnership with addition of Africa and Eurasia to provide Pepaxti to Patients

World Orphan Drug Alliance Expands to Japan & South Korea and the African Subcontinent World Orphan Drug Alliance Expands to Japan & South Korea and the African Subcontinent

World Orphan Drug Alliance Expands to China, Israel, and Greece, Cyprus, and Malta Greater China region, Israel, and Greece, Cyprus and Malta are now also covered by the alliance. With the addition of three new WODA members - RareStone Group, CTS, and Path Pharma - WODA now provides...

World Orphan Drug Alliance Announces Agreement with Theratechnologies for the Distribution of EGRIFTA SV Under the agreement, the World Orphan Drug Alliance (WODA) has obtained exclusive distribution rights to EGRIFTA SV® (tesamorelin for injection) to be made available under a Named Patient Program. The...